A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder

CompletadoFase 2ClinicalTrials.gov

ID: NCT00273039Tipo: INTERVENTIONALInicio: 1 de ago de 2005Fin estimado: 1 de sept de 2006

Traducción no disponible, mostrando original

Resumen

The purpose of this study is to test the safety and efficacy of GW679769 and paroxetine in subjects with Social Anxiety Disorder

Elegibilidad

Edad mínima: 18 YearsEdad máxima: 65 YearsSexo: ALL

Criterios de inclusión

Patients with Generalized Social Anxiety Disorder as the primary diagnosis.
If female, must commit to consistent and correct use of an acceptable method of birth control.

Criterios de exclusión

Patients with any other psychiatric disorder as a primary diagnosis or within 6 months prior to screening.
Patients with Body Dysmophic Disorder, Schizophrenia, Schizoaffective Disorder, or a Bipolar Disorder.
Patients who pose a current suicidal or homicidal risk or have made a suicide attempt within the past 6 months or have ever been homicidal.
Patients who have a positive urine test at screen for illegal drug use and/or a history of substance abuse or dependence (alcohol or drugs) within the past 12 months.
Patients with an unstable medical disorder.
Female patients who are pregnant, lactating, or planning to become pregnant during a specified time during the study.
Patients who are taking other psychoactive medications.

Intervenciones

drug

paroxetine

Ubicaciones

GSK Investigational Site

Buenos Aires, Buenos Aires, Argentina

GSK Investigational Site

La Plata/Buenos Aires, Buenos Aires, Argentina

GSK Investigational Site

Córdoba, Córdoba Province, Argentina

GSK Investigational Site

Buenos Aires, Argentina

Patrocinadores

PrincipalGlaxoSmithKline

Aviso: La información de este ensayo proviene de fuentes públicas y tiene carácter exclusivamente informativo. No constituye asesoramiento médico, regulatorio ni de ningún otro tipo. Las traducciones son automatizadas y no poseen validez oficial. Consultá siempre con un profesional de la salud. Ver Términos de Uso.

A Randomized, Double-Blind, Parallel Group, Placebo-Contr... | EligiMed